Junru Wu Selected Research

Junru Wu Research Topics

Disease

11	Neoplasms (Cancer) 11/2020 - 12/2006
9	Breast Neoplasms (Breast Cancer) 01/2016 - 06/2008
3	Inflammation (Inflammations) 01/2021 - 06/2017
2	Wounds and Injuries (Trauma) 12/2021 - 01/2021
2	Atherosclerosis 01/2018 - 01/2015
1	Atrial Fibrillation 01/2022
1	Brain Injuries (Brain Injury) 12/2021
1	Hemorrhagic Shock 12/2021
1	Chronic Disease (Chronic Diseases) 03/2021
1	Bacterial Infections (Bacterial Infection) 03/2021
1	Sepsis (Septicemia) 03/2021
1	COVID-19 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Disease Progression 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Cardiomegaly (Heart Hypertrophy) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 11/2020
1	Syringomyelia (Morvan's Disease) 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Arnold-Chiari Malformation (Arnold-Chiari Syndrome) 01/2019
1	Reperfusion Injury 06/2017
1	Myocardial Ischemia (Ischemic Heart Diseases) 06/2017
1	Ischemia 06/2017
1	Femoral Fractures (Femoral Fracture) 11/2015

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 11/2020 - 12/2006
4	Liposomes (Liposome)IBA 01/2014 - 06/2008
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2015
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2019 - 08/2017
2	Photosensitizing Agents (Photosensitizers)IBA 01/2019 - 08/2017
2	ferric oxide (iron oxide)IBA 01/2018 - 01/2015
2	IntegrinsIBA 08/2017 - 10/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014 - 12/2006
2	SuspensionsIBA 06/2008 - 12/2006
1	mesoglycanIBA 01/2022
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 12/2021
1	InterferonsIBA 12/2021
1	Complement System Proteins (Complement)IBA 12/2021
1	CadmiumIBA 03/2021
1	RNA (Ribonucleic Acid)IBA 03/2021
1	Heavy MetalsIBA 03/2021
1	Small Cytoplasmic RNAIBA 03/2021
1	LipidsIBA 01/2021
1	Phosphatidylethanolamines (Cephalins)IBA 01/2021
1	Paroxetine (Paxil)FDA LinkGeneric 01/2021
1	G-Protein-Coupled Receptor Kinase 2IBA 01/2021
1	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021
1	beta-1 Adrenergic Receptors (beta 1 Adrenergic Receptor)IBA 01/2021
1	Biological ProductsIBA 11/2020
1	Therapeutic UsesIBA 11/2020
1	MicroRNAs (MicroRNA)IBA 11/2020
1	Temozolomide (Temodar)FDA LinkGeneric 11/2020
1	GoldIBA 10/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2019
1	ProdrugsIBA 01/2019
1	tocophersolanIBA 01/2019
1	polydopamineIBA 01/2019
1	Tirapazamine (SR 4233)IBA 01/2019
1	Lysine (L-Lysine)FDA Link 08/2017
1	OligosaccharidesIBA 08/2017
1	Phenylalanine (L-Phenylalanine)FDA Link 08/2017
1	polyethylene glycol 1000IBA 08/2017
1	Succinic Acid (Succinate)IBA 08/2017
1	temoporfinIBA 08/2017
1	alpha-Tocopherol FDA Link 08/2017
1	aspartic acid glycine arginineIBA 08/2017
1	ChitosanIBA 08/2017
1	AntioxidantsIBA 06/2017
1	Oxidants (Oxidizing Agents)IBA 06/2017
1	HydrogenIBA 06/2017
1	2- (2- (2- chloro- 3- ((1,3- dihydro- 3,3- dimethyl- 1- propyl- 2H- indol- 2- ylidene)ethylidene)- 1- cyclohexen- 1- yl)ethenyl)- 3,3- dimethyl- 1- propylindoliumIBA 01/2016
1	Coloring Agents (Dyes)IBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	IodidesIBA 01/2016
1	Bovine Serum AlbuminIBA 11/2015
1	LipopeptidesIBA 10/2015
1	Contrast MediaIBA 10/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2013
1	Firefly LuciferasesIBA 01/2013

Therapy/Procedure

8	Microbubbles 06/2017 - 11/2008
3	Therapeutics 01/2019 - 01/2016
2	Drug Therapy (Chemotherapy) 11/2020 - 03/2013
2	Photochemotherapy (Photodynamic Therapy) 01/2019 - 08/2017
1	Electric Countershock (Cardioversion) 01/2022
1	Punctures 03/2021
1	Ligation 03/2021
1	Preoperative Exercise 01/2021
1	Tonsillectomy 01/2019
1	Operative Surgical Procedures 01/2019
1	Decompression 01/2019
1	Phototherapy (Light Therapy) 01/2019
1	Combination Drug Therapy (Combination Chemotherapy) 01/2019
1	Lasers (Laser) 01/2019
1	Photothermal Therapy 01/2019
1	Intravenous Injections 10/2015
1	Quantum Dots (Quantum Dot) 03/2013